Doxa AB
STO:DOXA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Doxa AB
Total Assets
Doxa AB
Total Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
Doxa AB
STO:DOXA
|
Total Assets
kr4B
|
CAGR 3-Years
31%
|
CAGR 5-Years
208%
|
CAGR 10-Years
70%
|
|
|
O
|
OssDsign AB
STO:OSSD
|
Total Assets
kr397.9m
|
CAGR 3-Years
8%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Xvivo Perfusion AB
STO:XVIVO
|
Total Assets
kr2.4B
|
CAGR 3-Years
11%
|
CAGR 5-Years
16%
|
CAGR 10-Years
28%
|
|
|
Bactiguard Holding AB
STO:BACTI B
|
Total Assets
kr545.1m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
V
|
Vimian Group AB
STO:VIMIAN
|
Total Assets
€1.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
S
|
S2Medical AB (publ)
STO:S2M
|
Total Assets
kr16.8m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
Doxa AB
Glance View
Doxa AB engages in the development, manufacture, and commercialization of bioceramic dental products. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2014-04-07. The firm develops, manufactures and commercializes products based upon its technology platform of calcium aluminate hydrate and bioactive ceramics. Activities are divided into the therapy areas of orthopedics and odontology. Research areas within orthopedics are methods for treating fractures resulting from osteoporosis, reconstructive orthopedics and coating of implants. Research areas within odontology are tooth restoration and implant fixation.
See Also
What is Doxa AB's Total Assets?
Total Assets
4B
SEK
Based on the financial report for Dec 31, 2025, Doxa AB's Total Assets amounts to 4B SEK.
What is Doxa AB's Total Assets growth rate?
Total Assets CAGR 10Y
70%
Over the last year, the Total Assets growth was -51%. The average annual Total Assets growth rates for Doxa AB have been 31% over the past three years , 208% over the past five years , and 70% over the past ten years .
